Ronald Blue Trust, Inc. Invitae Corp Transaction History

Ronald Blue Trust, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$0.42 - $0.72 $90 - $155	216 Added 90.0%	456 $0
Q3 2023 Oct 11, 2023	BUY	$0.6 - $1.53 $24 - $61	40 Added 20.0%	240 $0
Q2 2023 Jul 14, 2023	SELL	$1.05 - $1.63 $69 - $107	-66 Reduced 24.81%	200 $0
Q1 2023 Apr 17, 2023	BUY	$1.2 - $2.73 $79 - $180	66 Added 33.0%	266 $0
Q4 2022 Jan 17, 2023	SELL	$1.71 - $3.61 $203 - $429	-119 Reduced 37.3%	200 $0

Q3 2022 Oct 21, 2022	BUY	$1.9 - $8.63 $226 - $1,026	119 Added 59.5%	319 $0
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $426 - $1,802	200 New	200 $2,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.